- Home
- STK vs PACB Comparison
STK vs PACB Comparison
Compare STK & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STK
- PACB
- Stock Information
- Founded
- STK 2009
- PACB 2000
- Country
- STK United States
- PACB United States
- Employees
- STK N/A
- PACB N/A
- Industry
- STK Investment Managers
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- STK Finance
- PACB Industrials
- Exchange
- STK Nasdaq
- PACB Nasdaq
- Market Cap
- STK 434.6M
- PACB 364.2M
- IPO Year
- STK N/A
- PACB 2010
- Fundamental
- Price
- STK $28.94
- PACB $1.00
- Analyst Decision
- STK
- PACB Buy
- Analyst Count
- STK 0
- PACB 9
- Target Price
- STK N/A
- PACB $2.34
- AVG Volume (30 Days)
- STK 38.2K
- PACB 9.8M
- Earning Date
- STK 01-01-0001
- PACB 05-08-2025
- Dividend Yield
- STK 6.60%
- PACB N/A
- EPS Growth
- STK N/A
- PACB N/A
- EPS
- STK N/A
- PACB N/A
- Revenue
- STK N/A
- PACB $152,357,000.00
- Revenue This Year
- STK N/A
- PACB $4.01
- Revenue Next Year
- STK N/A
- PACB $18.54
- P/E Ratio
- STK N/A
- PACB N/A
- Revenue Growth
- STK N/A
- PACB N/A
- 52 Week Low
- STK $24.95
- PACB $0.85
- 52 Week High
- STK $34.31
- PACB $2.72
- Technical
- Relative Strength Index (RSI)
- STK 56.48
- PACB 44.98
- Support Level
- STK $28.25
- PACB $0.85
- Resistance Level
- STK $28.94
- PACB $1.10
- Average True Range (ATR)
- STK 0.39
- PACB 0.09
- MACD
- STK -0.03
- PACB 0.01
- Stochastic Oscillator
- STK 48.75
- PACB 50.00
About STK Columbia Seligman Premium Technology Growth Fund Inc
Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services. Columbia Management Investment Advisers, LLC serves as the investment manager to the fund.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.